Dr Reddys Laboratories (RDY) Net Margin Growth (3y) (2012 - 2023)

Dr Reddys Laboratories (RDY) Net Margin Growth (3y) (2012 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,620.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -98.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,358.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,235.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -100.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4,252.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -404.00
10 Dr Reddys Laboratories 9.82 Bn 9.66 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -71.00
Mar 31, 2023 769.00
Jun 30, 2021 408.00
Mar 31, 2021 -67.00
Sep 30, 2020 -2,472.00
Sep 30, 2019 -2,758.00
Mar 31, 2019 58.00
Dec 31, 2018 -251.00
Sep 30, 2018 -212.00
Jun 30, 2018 -489.00
Dec 31, 2017 -484.00
Sep 30, 2017 -735.00
Dec 31, 2016 -809.00
Sep 30, 2016 -296.00
Mar 31, 2016 6,381.00
Dec 31, 2015 -377.00
Sep 30, 2015 -332.00
Jun 30, 2015 203.00
Dec 31, 2014 47.00
Sep 30, 2014 62.00